Molecule Details
| InChIKey | YNUAEEJQYHYLMS-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | O=C1c2cc(-c3ccc(OC(F)(F)F)cc3)ccc2OCCN1Cc1ncccn1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 6.11 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12394 |
|---|---|
| Drug Name | Eleclazine |
| CAS Number | 1443211-72-0 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Eleclazine has been used in trials studying the treatment of LQT2 Syndrome, Long QT Syndrome, Ischemic Heart Disease, Ventricular Arrhythmia, and Long QT Syndrome Type 3, among others. |
Categories: Azepines
Cross-references: CHEMBL3707392 ChemSpider: 34993116 PubChem:71183216 PubChem:347828641 ZINC: ZINC000206191652